Last reviewed · How we verify

NCT06362408

Effect of Dexmedetomidine on Postoperative Mental Disorders and Long-term Survival in Elderly Patients

Completed Last updated 4 November 2024
What this trial tests

trial testing Dexmedetomidine in Cohort Studies in 6,000 participants. Completed in 1 June 2023.

Timeline
1 June 2022
Primary endpoint
25 May 2023
1 June 2023

Quick facts

Lead sponsorChinese PLA General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment6,000
Start date1 June 2022
Primary completion25 May 2023
Estimated completion1 June 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

Adults 65 to 110, any sex, with Cohort Studies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

China's aging population is causing an increase in the number of senior persons undergoing surgery. More and more clinicians are paying attention to the postoperative survival and mental health of elderly surgical patients. Dexmedetomidine (DEX) is an alpha-2 adrenergic agonist that works by inhibiting norepinephrine releasing renaline, which reduces inflammation and thus plays a protective role in the central nervous system. DEX has the potential to prevent and treat postoperative anxiety and depression in elderly patients undergoing non-cardiac surgery. Further exploration of evidence for evidence-based medicine is needed. Based on the above research background, this hypothesis is proposed: in elderly patients undergoing noncardiac surgery, intraoperative DEX is associated with a reduction in short-term postoperative mental disorders and a reduction in long-term postoperative mortality.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Association of Dexmedetomidine With Postoperative Depressive Symptoms in Older Surgical Patients: A Prospective Multicenter Study.
    Hao X, Zhang Z, Yang L, Guo Y, et al · · 2025 · cited 2× · PMID 40387522 · DOI 10.1111/cns.70407

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Cohort Studies

Currently open trials in the same condition.

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06362408.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing